1. Home
  2. |Insights
  3. |Business Disruption in a Pandemic: Does COVID-19 Excuse Non-Performance of a Contract

Business Disruption in a Pandemic: Does COVID-19 Excuse Non-Performance of a Contract

Webinar | 04.02.20, 9:00 AM EDT - 10:00 AM EDT

Register

As COVID-19 rapidly evolves and continues to disrupt your business operations in many ways, companies are increasingly confronting the challenges presented by force majeure and related doctrines in their contracts. Join us for a discussion on the five steps companies should consider as a follow on to the alert we previously shared. 


For more information, please visit these areas: Corporate and Transactional

Contact

Participants

Insights

Webinar | 05.14.26

Critical Reporting And Labeling Requirements for Products Containing PFAS: What Companies Need to Know (and DO) Now!

Because of recent changes to Federal and State law regulations, companies that manufacture, import, sell, or distribute products or equipment with components that contain certain “PFAS” materials face imminent and overlapping compliance obligations. This webinar will provide actionable information companies can use to determine whether they are impacted by these State and Federal requirements as well as practical advice for complying with these obligations. Topics that will be covered include the following:...

View All Insights